Pluripotent cells treat anemia?

Skin cells reprogrammed for pluripotency can be used to treat anemia in a mouse model of the disease, reports a study published online in Science today (December 6). The researchers, led by linkurl:Rudolph Jaenisch;http://www.wi.mit.edu/research/faculty/jaenisch.html and Jacob Hanna at MIT, say the study provides proof of principle that linkurl:induced pluripotent stem cells;http://www.the-scientist.com/blog/display/53873/ (iPS cells) can be used to treat diseases. The scientists first creat

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Skin cells reprogrammed for pluripotency can be used to treat anemia in a mouse model of the disease, reports a study published online in Science today (December 6). The researchers, led by linkurl:Rudolph Jaenisch;http://www.wi.mit.edu/research/faculty/jaenisch.html and Jacob Hanna at MIT, say the study provides proof of principle that linkurl:induced pluripotent stem cells;http://www.the-scientist.com/blog/display/53873/ (iPS cells) can be used to treat diseases. The scientists first created "humanized" mouse models for anemia by using gene knock-in techniques to replace mouse hemoglobin genes with human versions that cause the disease. Mice homozygous for the allele developed anemia symptoms and died within 18 months. They used four transcription factors -- Oct4, Sox2, Klf4 and c-Myc -- to generate lines of iPS cells from skin cells of the anemic mice. They then "corrected" these cells by replacing the diseased gene with its wild-type counterpart using homologous recombination techniques -- an approach that has been linkurl:used;http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&db=PubMed&cmd=Search&term=Blood%5BJour%5D%20AND%20108%5Bvolume%5D%20AND%201183%5Bpage%5D%20AND%202006%5Bpdat%5D%20AND%20Wu%5Bauthor%5D with ES cells. According to the paper, it worked comparably well in iPS cells. In the final step, they transplanted blood cells differentiated from the corrected iPS cells into three anemic mice. Using PCR, they showed that the DNA of the treated mice carried both the diseased and the corrected genes; a range of blood tests demonstrated that disease symptoms had improved to a state "comparable to control mice." But the researchers warn that major issues with the technique remain to be addressed before it can be used in treatment. One of the transcription factors they used in reprogramming iPS cells is believed to linkurl:cause tumors,;http://www.the-scientist.com/blog/display/53946/ and using retroviral vectors may also cause cancer.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Alla Katsnelson

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo